India’s cough syrup maker Maiden Pharmaceuticals tries to find more about Gambia deaths
Maiden Pharmaceuticals, an Indian cough syrup manufacturer, is in the process to find out from its buyer in the African state of Gambia details related to the deaths of children which according to the World Health Organisation (WHO), might have been linked to its products, one of its top officials said on Thursday (6).
“We are trying to find out the situation because it cropped up only today morning,” Naresh Kumar Goyal, a director, was quoted as saying by Reuters. “We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India.”
On Wednesday (5), WHO director-general Tedros Adhanom Ghebreyesus told reporters that the UN health agency was investigating 66 deaths caused from acute kidney injuries with India’s drug regulator.
Meanwhile, India was awaiting more information from the WHO on any links between an Indian-made cough syrup and the deaths of the children in Gambia, Reuters cited two Indian officials as saying on Thursday.